|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.48 THB | -0.80% |
|
-8.15% | -32.97% |
DOD Biotech Public Company Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was THB 294.49 million. Revenue was THB 298.26 million.
Net loss was THB 26.43 million. Basic loss per share was THB 0.06.
| 1st Jan change | Capi. | |
|---|---|---|
| -32.97% | 30.36M | |
| +17.10% | 8.44B | |
| +14.30% | 6.77B | |
| -3.69% | 3.81B | |
| -7.34% | 3.71B | |
| +1.78% | 1.4B | |
| -28.77% | 1.09B | |
| +18.84% | 1.03B | |
| -11.81% | 901M | |
| -18.34% | 785M |
DOD BIOTECH 
